Literature DB >> 35365313

Giant Pituitary Adenoma - Special Considerations.

Oliver Y Tang1, Wayne D Hsueh2, Jean Anderson Eloy3, James K Liu4.   

Abstract

Giant pituitary adenomas (GPAs) comprise 5% to 15% of pituitary adenomas, but have higher rates of extrasellar invasion, subtotal resection, surgical morbidity, and recurrence. With the possible exception of giant prolactinomas, GPAs require surgical decompression. On review of 3 decades of case series encompassing 699 microsurgical transsphenoidal (MT), 1060 endoscopic endonasal trans-sphenoidal (EET), and 513 transcranial (TC) patients, gross total resection and recurrence rates were comparable across modalities, but the EET approach had lower perioperative mortality and superior restoration of visual function. Each approach has unique indications. Combined EET-TC approaches for minimizing residual tumor represent another area of study.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopic endonasal surgery; Microsurgery; Neurosurgery; Pituitary adenoma; Skull base; Transsphenoidal surgery; Tumor; Tumor outcomes

Mesh:

Year:  2022        PMID: 35365313     DOI: 10.1016/j.otc.2021.12.008

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  1 in total

1.  Analysis of neuroendoscopy for the treatment of macroadenomas and giant pituitary adenomas.

Authors:  Junyong Wu; Binbin Zhang; Dongqi Shao; Shuxin Ji; Yu Li; Shan Xie; Zhiquan Jiang
Journal:  Front Surg       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.